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Abstract
Background Monocyte-macrophages play important roles
in choroidal neovascularization (CNV); however, the
mechanism is unclear. This study investigated the effects
of monocyte depletion on laser-induced CNV in mice,
especially the involvement of bone marrow-derived cells
(BMCs) and underlying molecular mechanisms.
Methods Clodronate-liposomes (lip) were used to deplete
monocytes and their effect on retinal pigmental epithelium
(RPE) cells, endothelial cells, and BMCs was analyzed. Green
fluorescent protein (GFP)-chimeric mice were developed by
transplanting bone marrow cells from GFP transgenic mice to
C57BL/6 J mice. CNV was induced by laser photocoagulation.
Chimeric mice were intravenously treated with clodronate-lip,
PBS-lip or PBS, 1 day before and after lasering. Histopatholog-
ical and choroidal flatmount analysis were performed tomeasure
CNV severity and BMCs recruitment. BMCs expression of
endothelial cell marker CD31 and vascular smooth muscle cell
marker α-SMA in CNVwere detected by immunofluorescence.
Expression of stromal cell-derived factor-1 (SDF-1) protein in
vivo was detected by immunofluorescence as well as ELISA
assay. SDF-1 was also examined by RT-PCR and ELISA in a
human monocytes-RPE cells co-culturing system.
Results No valid evidence for the toxicity of clodronate-lip
was found. Depletion led to significant inhibition of CNV
and BMCs recruitment into laser spots on days 3 and 14,
reduced BMC expression of CD31 and α-SMA on day 14,
and decreased expression of SDF-1 in vivo on day 3. SDF-
1 was mostly within and around the RPE cells in the laser
lesion. SDF-1 was dramatically up-regulated in RPE cells
after co-culturing with monocytes.
Conclusions Monocytes may promote experimental CNV,
especially BMC contribution in mice, by promoting SDF-1
production in RPE cells.
Keywords Choroidal neovascularization .Monocyte/
macrophages . Retinal pigment epithelium . Bone marrow
derived cells . Stromal cell-drived factor . Vascular
endothelial growth factor l
Introduction
Choroidal neovascularization (CNV) is a common patho-
logical endpoint for a variety of chorioretinal diseases.
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CNV causes 90% of all vision loss in age-related macular
degeneration (AMD), which is the most common cause of
blindness in the elderly in developed countries [1, 2]. As
life expectancy increases and the global population ages,
CNV, especially secondary to AMD, is increasing as a
socio-medical problem.
The molecular and cellular mechanisms underlying CNV
are not fully elucidated. Recently, evidence has suggested
the importance of immune system activation and inflam-
mation, particularly macrophages, in wet AMD, which is
characterized by CNV [3–6]. Macrophages are present in at
least 50% of CNV specimens, and may participate in all
stages of CNV [7]. Macrophages could modulate CNV
severity. Administration of interleukin-1 (IL-1) [8], tumor
necrosis factor-α (TNF-α) [9], IL-6 inhibitors [10], and
some antioxidant [11] and lipid-lowering drugs [12]
suppresses murine CNV and causes less macrophage
infiltration. Genetic ablation of the receptor for monocyte
chemotactic protein-1 (MCP-1) inhibits CNV in mice [13].
Depletion of macrophages with dichloromethylene
diphosphonate (clodronate)-liposomes (clodronate-lip)
reduces the size and leakage of laser-induced CNV [14,
15]. However, all in all, these studies mostly focused on the
effects of whole CNV severity and cell amounts without
looking into the detail, and thus leaving the mechanism
unsolved.
Previous studies have shown that in addition to cells in situ,
a lot of bone marrow-derived cells (BMCs) are recruited into
CNV and differentiated into endothelial cells (ECs) and
vascular smooth muscle cells (VSMCs), which indicates that
in addition to angiogenesis, vasculogenesis also plays an
important role in CNV development. It was reported that about
45% cells in laser-induced CNV was bone marrow derived.
Meanwhile, BMCs also modulate the severity of CNV [16–
18]. During this process, it is well-known that stromal cell-
derived factor-1 (SDF-1) is involved in recruiting BMCs and
also promoting CNV development [19]. We wondered
whether monocyte/macrophage depletion would affect BMC
recruitment that contributes to the CNV attenuation; in other
words, whether the roles of monocyte-macrophages in CNV
development might be mediated, in part, by modulating
vasculogenesis, and if this was true, whether SDF-1 would be
involved in it. In this experiment, we used laser-induced
CNV in C57BL/6A mice transplanted with bone marrow
cells from green fluorescent protein (GFP)-transgenic
mice to observe CNV progression, especially vasculogenesis
following monocytes-macrophage depletion. To detect the
mechanism, we also developed a model of monocyte-retinal
pigmental epithelium (RPE) cells co-culture in vitro to survey
the alteration of SDF-1. In addition, as clodronate-lip was
suspected to inhibit experimental CNV by damaging local
cells in the laser lesion [20], we firstly evaluated the effects of
clodronate-lip before going into the present research.
Materials and methods
Animals
Mice were handled in accordance with the ARVO State-
ment for the Use of Animals in Ophthalmic and Vision
Research. Female, wild-type 8-week-old C57BL/6 J mice
(Experimental Animal Center, The Fourth Military Medical
University) were divided randomly into three groups, and
the right eyes were used. Age-matched female GFP+/+
transgenic mice (C57BL/6 background, Institute of Neuro-
sciences, The Fourth Military Medical University) were
used for bone marrow transplantation.
Clodronate-liposome and PBS liposome preparation
and efficacy evaluation
Monocyte/macrophages were depleted by apoptosis induction
with clodronate-lip. Clodronate-lip and phosphate-buffered
saline (PBS)-liposomes (PBS-lip) were prepared as previously
described [21]. Briefly, 8 mg cholesterol (Sigma-Aldrich, St.
Louis, MO, USA) and 86 mg phosphatidylcholine (Lipoid
EPC; Lipoid, Ludwigshafen, Germany) were dispersed in
10 ml of 0.6 M clodronate solution (a gift of Roche
Diagnostics GmbH, Mannheim, Germany) and sonicated
gently. The suspension was centrifuged, and clodronate-lip
or PBS-lip were then resuspended in sterile PBS. The final
clodronate-lip suspension contained 5 mg of clodronate per
ml. PBS-lip was prepared under the same conditions, with
PBS instead of the clodronate solution.
To confirm depletion of monocyte-macrophages by
clodronate-lip, mice were given 0.2 ml clodronate-lip
intravenously, and after 2 days, anesthetized and perfused
transcardially with 20 ml 0.9% saline, then 50 ml 4%
paraformaldehyde. Spleens were harvested and dehydrated
in a graded alcohol series, embedded in paraffin, and
sectioned at 3 μm. Immunohistochemistry for monocyte-
macrophages in spleen was performed by deparaffinizing,
and microwaving in 0.01 mol/l sodium citrate buffer (pH 6,
10 min, 95-100°C) for antigen retrieval, then incubating in
3% H2O2 for 30 min at room temperature (RT). After
blocking with 5% bovine serum albumin (Sigma-Aldrich,
St. Louis, MO, USA) and 5% normal goat serum
(Zhongshan Biotechnologie Company, Beijing, China) in
PBS for 30 min, sections were incubated overnight at 4°C
with rat-anti mouse F4/80 primary antibodies (1:400;
Serotec, Raleigh, NC, USA), then biotinylated goat anti-
rat second antibody (1:200; Zhongshan Biotechnologie
Company, Beijing, China) for 30 min at 37°C, and
streptavidin–horseradish peroxidase at 37°C for 30 min. A
3-amino-9-ethylearbazole substrate kit (Zhongshan Bio-
technologie Company, Beijing, China) was used at RT for
staining, with counterstaining with hematoxylin. GVA
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mounting solution (Zhongshan Biotechnologie Company,
Beijing, China) was applied to mount coverslips.
Tracing liposomes and assessment of clodronate toxicity
To assess if clodronate-lip was toxic to eyes after lasering in
vivo, we traced liposomes in mice by labeling PBS-lip with
3,3′-dioctadecyloxacarbocyanine perchlorate (DiO). Briefly,
2.2 mg DiO (Beyotime Institute of Technology, China)
were added to 1 ml 100% ethanol and sonicated in a
waterbath at 50 kHz for 1 min. Then 10 μl DiO solution
was added to 1 ml PBS-lip. The mixture was shaken and
incubated at RT for 10 min in dark. After two washes at
20,000×g for 10 min, the supernatant was removed and
sterile PBS was added to restore the original volume. After
resuspension, the mixture was kept in dark at 4°C. Labeling
was confirmed by fluorescence and light microscopy
(BX51, Olympus, Tokyo, Japan). Four C57 mice were
injected with lip-DiO intravenously 1 day before and after
lasering, and sacrificed at day 3. Then choroidal flatmounts
and frozen sections of posterior eye were prepared as
described below. Flatmounts were then directly observed
under laser scanning confocal microscopy (Fluoview 1000;
Olympus, Tokyo, Japan), and frozen sections were immu-
nostained for macrophage markers F4/80 (1:400; Serotec,
Raleigh, NC, USA), endothelial cell marker CD31 (1:150,
Chemicon, Temecula, CA, USA), and RPE cell marker
cytokeratin (1:100; Santa Cruz Biotech, Santa Cruz, CA,
USA), followed by Texas red or tetraethyl rhodamine
isothiocyanate (TRITC)-conjugated second antibody (1:200
Abcam, Cambridge, MA, USA or 1:150, Jackson, West
Grove, PA, USA). Finally, sections were counterstained with
40, 6-diamino-2- phenylindole (DAPI; Molecular Probes,
Eugene, OR, USA) and observed under laser scanning
confocal microscopy.
Effects of clodronate-lip on proliferation and angiogenic
function of RPE and ECs were also tested. Human RPE
(hRPE) cells were cultured as previously described, in
accordance with the Helsinki agreement [22]. Fetal rhesus
choroid-retinal endothelial cells (RF/6A) cells were from the
Shanghai Institute for Biological Sciences. RPE were plated
at 1×104 cells/ml, while RF/6A were plated at 2×104 cells/
ml in 96-well plates in 200 μl DMEM with 10% fetal bovine
serum (FBS, Hangzhou Sijiqing Biological Engineering
Materials Co., Ltd. China), and allowed to adhere overnight
before 20 μl clodronate-lip or PBS-lip was added. Cell
proliferation was measured by 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl tetrazolium bromide (MTT)assay at 24 and
48 h. Briefly, 20 μl MTT was added in each well after
removing media, and incubated for 4 h. Formazan crystals
were dissolved in 150 μl dimethyl sulfoxide, and optical
density was read at 570 nm and 450 nm. To evaluate whether
clodronate-lip would affect angiogenic function of RPE cells,
VEGF and SDF-1α expression in RPE cells after being
cultured with clodronate-lip or PBS-lip was tested by
enzyme-linked immunosorbent assays (ELISA).
In addition, we also tested the effect of clodronate-lip on the
BMCs, which is a heterogeneous cell population comprised of
multiple types of stem/progenitor cells and is reported to be
incorporated into the CNV by differentiation into ECs and
SMCs using the well-established plastic-adherent methods
[23]. Briefly, bone marrow cells from tibias and femurs of 4-
week-old female C57BL/6 mice were cultured on plastic
dishes in Dulbecco’s modified Eagle’s medium supplemented
with 15% fetal calf serum (Gibco, Grand Island, NY, USA)
and incubated at 37°C with 5% CO2 in an incubator. After
3 days, nonadherent cells were removed by washing with
phosphate-buffered saline, and the remaining monolayer cells
were cultured in fresh medium until they reached confluence.
After 6–7 days, cells were trypsinized (0.25% trypsin with
0.1% EDTA). Then the cells of primary culture were plated at
5×103 cells/ml in 96-well plates, and then the MTT assay
was performed at 24 h and 48 h as described above, and
optical density was read at 492 nm.
Bone marrow transplantation and analysis of chimerism
Chimeric mice were generated by bonemarrow transplantation
and qualified by chimerism analysis as previously described
[24]. Briefly, unpurified bone marrow cells from GFP-
transgenic mice were injected into tail veins of irradiated
wild-type C57BL/6 J mice (2×106 per mouse). After 4 weeks,
peripheral blood was analyzed by fluorescence activated cell
sorter (FACS) scan to determine the degree of chimerism.
Induction of CNV and administration of clodronate-lip
and PBS-lip
Laser photocoagulation was performed on the right eyes of
qualified chimeric mice or C57BL/6 J mice using a 532 nm
laser (Iris Radiation Systems, USA; spot size 75 μm, power
100 mw, duration 0.1 s) through a contact lens. Six laser
spots were applied between the major retinal vessels 1.5-2
disc diameters from the optical disc. Disruption of Bruch’s
membrane was confirmed when a cavitation bubble
appeared without hemorrhage. For systemic depletion of
macrophages, chimeric mice received 0.2 ml of cloronate-
lip (clodronate mice) intravenously 1 day before and after
the laser procedure. Control mice received PBS-lip (PBS-
lip mice) or PBS (PBS mice) at the same time points.
Measurement of lesion severity
Histopathological analysis was performed as described
previously [24]. Mice were killed 2 weeks after lasering
(n=4 per group). Prepared paraffin sections of eye cups
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were processed with hematoxylin and eosin (H&E), and
CNV thickness was measured as described below.
Choroidal flatmount was performed on day 14 after
CNV induction (n=4 mice/group/time point) as described
previously [25]. Anesthetized mice were perfused trans-
cardially with 0.9% saline followed by 4% paraformalde-
hyde. Eye globes were enucleated and then the anterior
segment and the neural retina were removed. The remained
RPE-choroid-sclera complex was flatmounted with six
radial cuts or more, and then permeabilized in 0.2% Triton
X-100 for 24 h, before transferring into 1:1,000 rhodamine-
conjugated Ricinus communis agglutinin (Vector Laboratories,
Burlingame, CA, USA) for 24 h, followed by washing in
0.01 M Tris-buffered saline Tween-20 (TBST) for 24 h.
Flatmounts were examined and photographed by confocal
laser scanning microscopy, and CNV area was assessed as
described in image analysis section.
Analysis of BMC recruitment and differentiation
Flatmounts made from the three groups of mice on days 3
and 14 were analyzed for BMC recruitment. Serial cross-
sections of eyes were also prepared to calculate the number
of BMCs in the lesion. Briefly, on days 3 and 14 the
clodronate- and PBS-lip mice (n=4 mice/group/time point)
were perfused transcardially after lasering as described
above. The right eyes were removed and post-fixed in 4%
paraformaldehyde for 2 h at 4°C. After cryoprotection in
30% sucrose in 0.1 M phosphate buffer overnight at 4°C,
vertical sections were cut on a cryostat (12 μm; RM31;
Leica, Heidelberger, Nussloch, Germany) and mounted on
gelatin-coated slides. For sections from day 14, endothelial
and vascular smooth muscle cells (VSMCs) derived from
BMCs in CNV were identified by immunofluorescence,
performed as described [20]. Serial cross sections were
incubated with primary antibodies against CD31 (1:500),
α-SMA (1:600; Neomarkers, Fremont, CA, USA), Texas
Red or TRITC-conjugated secondary antibodies, and finally
counterstained with DAPI. Slides were coverslipped with
anti-fading medium, and examined with the confocal laser
scanning microscope as described in image analysis
section. In addition, to determine whether decreased BMCs
in the lesions were more than or just the blood-derived
macrophages, frozen sections from chimeric mice were
immunostained for macrophage markers F4/80 (1:400;
Serotec, Raleigh, NC, USA) to assess the ratio of F4/80
positive BMCs, which indicated blood-derived macro-
phages to total BMCs on days 3 and 14.
SDF-1 protein expression in the eye
The amount of SDF-1 protein expression in clodronate and
PBS-lip mice on day 3 after lasering was determined by
immunofluorescence in sections and also ELISA assay. To
detect SDF-1 expression in the lesion, serial cross-sections
of eyes (n=4 per group) were incubated with primary
antibody of SDF-1(1:150, Santa Cruz, CA, USA). After
being incubated with TRITC-conjugated secondary anti-
body and counterstained with DAPI, sections were ana-
lyzed under the laser scanning confocal microscope. SDF-1
levels in eyes (n=4 per group) were determined by using a
mouse SDF-1 ELISA kit (USCN Life Science and
Technology).At day 3, eyes were removed and prepared
for ELISAs as previously reported [23]. Eyes were quick-
frozen in 100 μl of phosphate-buffered saline (pH 7.4) with
0.05% phenylmethylsulfonyl fluoride and homogenized
manually on ice, followed by three freeze–thaw cycles on
liquid nitrogen and wet ice. The homogenates were
centrifuged in a refrigerated desktop centrifuge to pellet
the insoluble material, and the supernatants were collected.
ELISAs were performed following the manufacturer’s
instructions.
To search for the main contributor of SDF-1, immuno-
fluorescence for RPE cells and SDF-1 was performed
simultaneously in the sections from mild C57/BL mice on
day 3, based on the fact that RPE cells have been
considered as the main source of SDF-1 in human CNV
[26]. Sections were incubated with primary antibodies
against pan-cytokeratin (CK) (1:150, Santa Cruz, CA,
USA), SDF-1 (1:150, Santa Cruz, CA, USA), and then
TRITC and FITC-conjugated secondary antibodies, and
finally counterstained with DAPI, examined under the
confocal laser scanning microscope. The relationship of
SDF-1 and RPE cell positions was assessed.
Image analysis
H&E-stained sections were digitized with a color video
camera connected to a light microscope. Flurorescence
images were captured by Fluoview 1000 (Olympus, Tokyo,
Japan). Images were analyzed by Image Pro Plus software.
Morphometric data for lesions were averaged per eye. Data
of each group were calculated and expressed as mean ±
standard deviation (SD).
To measure CNV thickness, consecutive H&E sections
were examined to select intact CNV. CNV thickness was
then measured vertically from the adjacent RPE layer to the
top of the CNV and expressed in μm. A single CNV
thickness was represented by the maximum data of all of its
consecutive sections. For measuring CNV surface area, the
agglutinin-positive red area at the laser spots in the
flatmounts was measured and expressed in μm2.
For assessing BMC recruitment and incorporation into
the laser spot at days 3 and 14, GFP positive cell areas in
each laser lesion in the flatmounts were measured and
expressed in μm2. Comparisons were between averages of
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groups. To assess constituent ratios of BMCs in the lesion,
nuclei overlapped with or without GFP were counted
respectively in the laser spots in the sections of posterior
eyes. To assess constituent ratio of macrophages, the
number of F4/80-positive BMC cells was counted and
divided by the total number of BMCs in the lesion of wild-
type mice on days 3 and 14 after lasering. For BMC
differentiation, green fluorescence surrounded by red
fluorescence was considered to be differentiated BMCs.
Only cells with a DAPI-labeled nucleus were included. For
detecting macrophages, ECs, and RPE cells for toxicity
assessment, red (TRITC) membranes surrounding a clearly
blue (DAPI) nucleus were considered to be positive. For
assessing SDF-1 protein expression at laser spots, TRITC
fluorescence intensity (FI) was determined and averaged.
Monocyte isolation
Human monocytes were freshly isolated from the peripheral
blood of healthy volunteers as previously described [27], in
accordance with the Helsinki agreement. Briefly, peripheral
blood was drawn into a heparinized syringe and diluted 1:1
in 0.9% saline. Mononuclear cells were separated by
density gradient centrifugation using lymphocyte separation
medium (LOTS1077, Tianjin Haoyang Biological Technolo-
gy). Cells were washed and layered onto a slightly hyper-
osmolar Percoll gradient (density=1.064 g/ml) for the
enrichment of monocytes. Percoll solutions were made as
follows. First, an isosmotic Percoll was prepared by mixing
one volume NaCl 1.5 M with nine volumes of Percoll
(Pharmacia, density=1.130 g/ml). The Percoll gradient was
made by mixing 1:1 (v/v) isosmotic Percoll with PBS/Citrate
(NaH2PO4 1.49 mM; Na2HPO4 9.15 mM; NaCl
139.97 mM; C6H5Na3O7 .2H2O 13 mM; pH 7.2). Cells
were incubated with CD14 antibody (eBioscience, San
Diego, CA, USA) and analyzed by flow cytometry to assess
the purity.
Cell culture and RPE-monocyte co-culture
HRPE cells were used at cell passages 4 to 6. For hRPE cell
and monocyte co-culture [28, 29], 2×105 hRPE were plated
in 6-well plates and incubated overnight in DMEM contain-
ing 10% FBS without antibiotics. Freshly enriched monocyte
populations at 4×105 were directly overlaid onto hRPE cells.
Non-contact co-culturing was performed by implanting
monocytes in Millicell (Millipore, Bedford, MA, USA),
separating monocytes from hRPE with porous polycarbonate
filters. After incubating for 4 or 24 h, conditioned media
were harvested and centrifuged at 1000 x g for 10 min, and
stored at −80°C for ELISA. To determine protein sources,
hRPE cells and monocytes were harvested respectively after
co-culturing for 4 h and being separated by being incubated
with cold Ca2+- and Mg2+- free PBS containing 5 mM
EDTA for 3 min. PCR was used to detect mRNA.
ELISA assay of SDF-1α in vitro
SDF-1α concentrations were quantified with a sandwich
ELISA kit (R&D Systems, Minneapolis, MN, USA and
Beijing 4A Biotech, Beijing, China), according to the
manufacturer’s protocol. Standards were 0.5-log protein
dilutions from 200 pg to 3.125 ng/well. The minimum amount
of detectable chemokines was 0.8 pg / ml for SDF-1α.
RT-PCR
RNA was extracted with Trizol (Invitrogen, Carlsbad, CA,
USA) and converted to cDNA with a RevertAid First
Strand cDNA Synthesis Kit (Fermentas, Burlington, ON,
Canada). The amplification program was 95°C for 10 min,
followed by 95°C for 10 s, and 60°C for 30 s, for 40 cycles.
Primers for RPE cells were GAPDH sense, 5′-GCG CTG
AGT ACG TCG TGG AG-3′; GAPDH antisense, 5′-CAG
TTG GTG GTG CAG GAG G-3′; SDF-1 sense, 5′-GAT
TGTAGC CCG GCT GAA GA-3; SDF-1 antisense, 5′TTC
GGG TCA ATG CAC ACT TGT-3. After amplification,
samples were run on a 1.5% agarose gel (Sigma, Poole,
UK) in TBE (0.045 M Tris-borate, 0.001 M EDTA)
containing 0.4 mg/ml ethidium bromide, and bands were
photographed on a UV transilluminator. Relative abun-
dance of product was assessed as the ratio of the aimed
gene band to the GAPDH band for each sample, using
Kodak Digital Science 1D software.
Statistical analysis
Data from quantitative assays are expressed as mean ± SD.
One-way ANOVA analysis was used for statistical analysis for
CNV thickness and area on day 14, and GFP cells area on days
3 and 14. Independent samples t-test was used for the others.
SPSS software 11.0 (SPSS Inc., Chicago, USA) was used.
Results at P<0.05 were considered statistically significant.
Results
Assessment of efficiency and toxicity of clodronate-lip
Spleen sections of clodronate-lip-treated mice showed few
macrophages, while many macrophages were found in the
spleens of PBS-lip-administered mice (Fig. 1a, b), confirming
the efficacy of clodronate-lip treatment. All liposomes were
green by fluorescent microscopy, implying 100% labeling
(Fig. 1c). After intravenous injection into mice, liposome-
DiO was detected at laser spots in the choroidal flatmounts
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3 days after lasering (Fig. 1d). Labeled liposomes could also
be detected in the laser lesion in cross sections. By
immunofluorescence, liposomes were found adjacent to, or
enclosed by macrophages (Fig. 1e), and not enclosed by RPE
cells or ECs (Fig. 1f, g). In vitro, there were no significant
difference in OD values revealed by MTT assay between
RPE cells cultured with PBS-lip or clodronate-lip at 24 and
48 h (P>0.05, Fig. 1h). Situation was similar for RF/6A cells
(P>0.05, Fig. 1i) and also the BMCs (P>0.05, Fig. 1j),
indicating that compared with PBS-lip, clodronate-lip was no
more harmful to RPE or endothelial cell proliferation. VEGF
protein level in the supernatant of RPE cells cultured with
clodronate-lip was similar to that of PBS-lip-treated cells
(1108.94±176.58 vs 998.1±126.94 pg/ml, P>0.05), while
SDF-1α was not detected in the supernatant of RPE cells
cultured neither with PBS-lip nor clodronate-lip.
Generation of chimeric mice
Four weeks after bone marrow transplantation, the survival
rate of mice transplanted with exogenous bone marrow was
100%. The mean percentage of circulating karyocytes
identified as transplanted cells by GFP expression was
91.45%±2.22%, indicating the success of the bone marrow
transplantation.
Reduction in CNV severity and recruitment of BMCs
into the lesion
After monocyte depletion, CNV development and recruitment
of BMCs were investigated on days 3 and 14 to assess effects
of monocyte deprivation. In choroidal flatmounts, CNV area
of the clodronate group was markedly smaller than that of the
PBS and PBS-lip groups on day 14 (4713.89±1537.72 vs
9240.05±1971.41 vs 9596.35±2120.70 μm2, P<0.05,
Fig. 2a, b, g). In the cross section,CNV thickness of the
clodronate group was thinner than that of the PBS and PBS-
lip groups (23.57±2.31 vs 30.61±1.65 vs 29.21±1.82 μm,
P<0.05, Fig. 2c, d, h), while there was no significant
difference in CNV area and thickness between the two
control groups. GFP-positive cells were detected within the
laser spots on days 3 (Fig. 2e, f) and 14 (Fig. 2a, b) in the
flatmounts. Clodronate mice demonstrated smaller GFP-
positive cells areas on both day 14 and day 3, while
the PBS and PBS-lip groups were similar to each other
(236.62±74.71 vs 2606.24±460.61 vs 2651.58±500.5 μm2
for day 14, P<0.05, Fig. 2I; 190.99±60.45 vs 2699.61±
550.8 vs 2753.82±596.96 μm2 for day 3, P<0.05, Fig. 2j).
Then, cell number was further counted in the laser spots in
cross-sections. The number of GFP-positive cells was found
decreased in clodronate mice on days 3 (3.1±1.45 vs 18.58±
4.27, P<0.05) and 14 (1.6±1.35 vs 20.57±3.15, P<0.05),
while the number of non-GFP-positive cells, representing the
resident cells, was similar to the PBS-lip group on day 3
(8.44±3.00 vs 9.55±2.46, P>0.05), but was less than PBS-
lip mice on day 14 (8.3±3.34 vs 20.57±4.20, P<0.05).
Then, using these numbers to calculate the constituent ratio
of GFP-positive cells to total number showed that the ratio of
BMCs decreased from 66.1% (PBS-lip group) to 26.9%
(clodronate group) on day 3, and from 50% (PBS-lip group)
to 16.2% (clodronate group) on day 14. However, many
GFP-positive cells remained beneath the lesions in clodro-
nate mice, similar to the PBS-lip mice. Furthermore, GFP-
positive cells that differentiated into ECs and VSMCs were
rare in clodronate mice (Fig. 3a, c), while differentiated
BMCs were easily found in PBS-lip mice (Fig. 3b, d). In
addition, we found that approximately 30% of BMCs were
F4/80 positive on day 3,and 10% on day 14.
SDF-1 expression
Local SDF-1 protein expression in the lesions on day 3 was
investigated to determine the potential mechanism of the
monocyte depletion effects. Cross-sections indicated that local
SDF-1 protein expression was dramatically decreased after
monocyte depletion (Fig. 4a, b), and this was confirmed by
fluorescent intensity measurements [(7.0±5.0)×104 vs (86.8±
21.1)×104 FI, P<0.01)] and ELISA assay (578.5±54.9 vs
1603.2±86.2 pg / eye, P<0.01). SDF-1 was mainly
expressed in or adjacent to RPE cells (Fig. 4c).
SDF-1 mRNA and protein expression were tested in a
co-culture system, with monocyte purity greater than 90%.
SDF-1α protein was undetectable at 4 or 24 h in RPE cells
cultured alone. Contact co-culture of RPE and monocytes
significantly stimulated expression of SDF-1α to detectable
levels. SDF-1α in the supernatant from contact co-cultures
of monocytes and RPE cells was higher than in the Millicell
at 4 and 24 h (583.74±57.86 vs 187.67±21.61 pg/ml for
4 h, P<0.01; 934.08 ±19.83 vs 263.36±48.04 for 24 h, P<
0.01, Fig. 5a). This indicated that contact with monocytes
was crucial, and potently stimulated SDF-1α protein
production. SDF-1 mRNA levels were low in RPE cells
cultured alone, and in monocytes co-cultured with RPE
Fig. 1 Assessment of efficiency and toxicity of clodronate-liposomes.
Immunostaining for F4/80 shows macrophages (red) in spleen
sections of PBS-liposome (lip) mice (a) and almost no positives in
clodronate mice (b). PBS-lip was investigated under fluorescence
(upper insert) and light microscope (lower insert), and the merged
figure indicated 100% labeling (c). After tail injection, DiO labeled
liposome (green) appeared in flatmounts within the laser lesion (d).
Liposomes (green, arrow in e, f, g) were phagocytosed by macrophages
(arrowhead, e) in the laser lesion at day 3, but not by retinal pigmental
epithelium (RPE) cells (arrowhead, f) or endothelial cells (arrowhead, g).
The nucleus was counterstained by DAPI (blue). Bar=50 μm. MTT
assay showed similar optical density (OD) values for RPE cells cultured
with PBS-lip and clodronate-lip (h), and also the OD value for RF/6A (i),
and BMCs (j) (n=3, P>0.05)
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cells, but SDF-1 mRNA levels were obviously elevated in
RPE cells after co-incubation with monocytes (Fig. 5b).
Discussion
Monocytes have long been closely linked to adult angiogenesis
including tissue repair, remodeling, or tumors. Abolishment of
monocytes drastically reduces angiogenesis. Specific chemo-
attraction of monocytes highly amplifies angiogenesis
[30–32]. Similarly, several experiments have confirmed
monocyte-macrophages also modulate CNV severity, as
reviewed above. However, the potential mechanism of the
modulation remains unclear. In this study, we made efforts to
survey the effect of monocyte absence on vasculogenesis,
which has recently been considered as one of the important
contributors to CNV development.We also tried to investigate
the mechanisms of the effects, in vivo and in vitro.
To deplete monocytes, we used clodronate-lip, which has
recently beenwidely used in animal experiments for evaluating
angiogenesis effects [14, 15] (see more at www.clodronate
liposomes.org). This drug is selectively ingested by macro-
phages, inducing apoptosis without affecting any other cells.
The number of macrophages in peripheral blood and tissues
is markedly decreased by this drug, and the effects last for
24–48 h. It is believed to be a safe and stable method for
monocyte-macrophage depletion [33]. However, it has been
argued that choroidal endothelial cells may be susceptible to
clodronate-lip, because liposomes may leak into the laser
lesions [34]. In our study, it was true that liposome-DiO could
be seen in the laser lesions on day 3, while none were
encapsulated by ECs or RPE cells. In addition, clodronate-lip
did not inhibit proliferation or VEGF, SDF-1α production of
RPE or RF/6A cells compared to PBS-lip, suggesting a lack
of toxicity against endothelial and RPE cells, since VEGF
and SDF-1 are both potent angiogenic factors in the
neovascularization process. In addition, considering that
BMCs are also the main constituent cells in laser spots, we
further tested the effects of clodronate-lip on its proliferation
Fig. 3 Incorporation of bone marrow derived cells (BMCs) and
differentiation in choroidal neovascularization (CNV) on day 14.
Clodronate mice (a, c) demonstrated smaller CNV (dotted line) and
very few BMCs (green) compared with controls (b, d). Almost no
BMCs differentiated to endothelial cells (EC, red) (a) or vascular
smooth muscle cells (VSMCs, red) (c) in clodronate mice. While more
EC (red), VSMCs (red), and BMCs (green) were seen in control mice,
and among them some BMCs differentiated into EC (b) or VSMCs (d)
(arrow), many BMCs (green) were also observed beneath the CNV in
both clodoronate and control mice. Bar=50 μm
Fig. 2 Morphometry of choroidal neovascularization (CNV) and
recruitment of bone marrow derived cells (BMCs) into lesions. On day
14, CNV (solid line) formed around the optical disc (dotted line), as
represented in choroidal flatmounts (a, b). Compared with PBS-
liposome (lip) mice (a), clodronate mice (b) showed smaller CNV
areas and decreased green fluorescent protein (GFP) positive cell
(indicating BMCs) recruitment (green or yellow cells from red
overlap). Insert: amplified figure of a single CNV. Cross sections of
control mice [c showed larger and thicker CNV compared with
clodronate mice (d)]. Choroidal flatmounts at day 3 showed more
BMCs (green) at the lesion in control mice (e) than in clodronate mice
(f). Bar=50 μm. Statistical analysis showed clodronate mice demon-
strated smaller CNV thickness (23.57±2.31 vs 30.61±1.65 vs 29.21±
1.82 μm, P<0.05, i), CNV area (4713.89±1537.72 vs 9240.05±
1971.41 vs 9596.35±2120.70 μm2, P<0.05, h) and BMC area
(236.62±74.71 vs 2606.24±460.61 vs 2651.58±500.5 μm2 for day
14, P<0.05, I; 190.99±60.45 vs 2699.61±550.8 vs 2753.82±
596.96 μm2 for day 3, P<0.05, j). (*P <0.05 vs PBS, PBS-lip mice).
Data for the two control groups were similar (P>0.05)
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in vitro, yet still no apparent negative affect was observed.
But more extensive investigation, such as ultrastructure
examination, might be needed to completely rule out the
toxicity of clodronate-lip in the future.
We confirmed that monocyte depletion dramatically
decreased the area of CNV, which was consistent with the
previous reports [14, 15]. Meanwhile, significantly fewer
BMCs were recruited into laser spots on days 3 and 14, as
demonstrated by choroidal flatmounts. As there were no
significant differences between the PBS-lip and PBS
groups, we then cut down the two control groups to only
one, and thus focused our comparison on clodronate and
PBS-lip mice.
Consistently, in posterior eye sections, significantly fewer
BMCs and reduced ratio of BMCs were detected at the laser
spots in monocyte-depleted mice. However, by counting cell
nuclei, the resident cell number was nearly the same between
monocyte-depleted mice and controls on day 3. This implied
that monocyte depletion mainly affected BMC recruitment,
rather than resident cells, at this early stage. However,
someone may argue that depleting monocytes would certainly
diminish BMCs, because monocytes in CNV are mostly
blood-derived, and originally released from the bone marrow
[35, 36]. Therefore, we further calculated the number of
macrophages, and found that approximately 30% of BMCs
were F4/80 positive on day 3, and about 10% on day 14.
Since actually more than 80-90% of BMCs were undetectable
after monocyte depletion, we thus confirmed that in addition to
monocyte-macrophages, other BMCs were indeed diminished
on days 3 and 14. Further, very few BMCs were embedded in
the CNV membrane on day 14 and almost no BMCs
differentiated into ECs or VSMCs after monocyte depletion,
Fig. 5 Stromal cell-derived factor-1 (SDF-1) mRNA and protein
expression in the co-culture system. As shown in the statistical
analysis (a), SDF-1α was dramatically enhanced after contact with
monocytes at 4 h and 24 h, and was greater than in the Millicell
system (583.74±57.86 vs 187.67±21.61 pg/ml for 4 h; 934.08±19.83
vs 263.36±48.04 for 24 h, n=4, *P<0.01 vs millicell co-culture );
PCR showed SDF-1 mRNA could be detected in retinal pigmental
epithelium (RPE) cells after contact with monocytes, but not in RPE
cells cultured alone or in the Millicell system (b)
Fig. 4 Expression of stromal cell-derived factor-1 (SDF-1) on day 3.
There were many bone marrow derived cells (BMCs, green) in the
laser lesion with high expression of SDF-1 (red) in control mice (a),
while clodronate mice had got few BMCs (green) and low protein
expression (red) (b). Bar=50 μm. The SDF-1 (green) were mostly
expressed adjacent or within the RPE cells (red) (c). Bar=10 μm
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indicating lower incorporation of BMCs in the vessels in
mature CNV. Interestingly, in spite of fewer BMCs in CNVon
days 3 and 14, many BMCs were also found in the choroid
beneath the CNV membrane. We then examined the local
SDF-1 expression, trying to unveil the mechanism.
We, for the first time, demonstrated a decrease in SDF-1
after monocyte depletion. The decreased SDF-1 expression in
laser spots and in the whole eye on day 3 might explain the
reduced recruitment of BMCs in CNV. SDF-1 facilitates the
migration and homing of BMCs, and promotes firm adhesion
of BMCs to the vessel endothelium by increasing the
expression of vascular cell adhesion molecule on the EC.
SDF-1 increases the permeability of ECs, facilitating the
migration of BMCs [37, 38]. Recently, the retention of
marrow-derived circulating cells in close proximity to
angiogenic vessels has been reported to be mediated by
SDF-1 [39]. Based on this information, we hypothesized that
although decreased, SDF-1 levels in the lesions of monocyte-
depleted mice were still higher than the surrounding cells,
which resulted in the recruitment of many BMCs to the
choroid beneath CNV, but failed to cause BMC migration
out of choroidal vessels into the subretinal space, or to
maintain them for CNV formation by differentiating into
vessel constituents such as ECs and VSMCs. So why did
SDF-1 decrease? Interestingly, we noticed that in an
ischemia model, monocyte depletion did not affect local
levels of SDF-1 after femoral artery excision, which
excluded monocytes as the SDF-1 generator [40]. This
suggested another contributor of SDF-1 that is affected by
monocyte depletion during CNV formation.
Using the immunofluorescence method, we found that
SDF-1 protein was mostly expressed at or around the RPE
layer, which indicated RPE cells as the main contributor of
SDF-1 in the lesions. A previous experiment also has
implied that RPE cells may be the most important source of
SDF-1 in human CNV [26]. RPE cells are sensitive to
inflammatory agents and monocyte interaction [41]. Mono-
cyte extravasation and cell–cell contact between monocyte-
macrophages and RPE cells are sequential events during
AMD [42]. Macrophages are found adjacent to RPE in
experimental CNV [43]. Therefore, we assumed that it was
interaction of monocyte-macrophages and RPE cells pro-
moting SDF-1. We thus performed in vitro monocyte–RPE
co-culturing, and found that SDF-1 secretion was largely
promoted by direct contact with monocytes, while SDF-1 in
RPE cells cultured alone was undetectable by ELISA,
similar to results reported by Isabel et al., who found that
SDF-1α production by RPE cells could be detected by
ELISA, but only at levels near the detection limit (1.33±
1.0 pg/ml) [44]. We also showed that direct contact with
monocytes was significantly more potent for stimulating
SDF-1 production in the supernatant than indirect contact
through a polyporous membrane. To tell the exact resource
of enhanced SDF-1 protein, we next examined SDF-1
mRNA by PCR. It showed that RPE cells cultured alone
also constitutively expressed SDF-1 mRNA, but very
weakly. After co-culturing, SDF-1 mRNA expression was
up-regulated in RPE cells, while expression in monocytes
was very low. This indicated that the enhanced protein was
mostly from RPE cells, and thus demonstrated that contact
with monocyte could considerably stimulate SDF-1 produc-
tion in RPE. So after laser induction, monocyte infiltration
would stimulate SDF-1 in the lesion.
In addition, a positive cycle for promoting vasculogenesis
could be expected when monocytes infiltrated laser spots.
SDF-1 is able to recruit monocytes [39, 45, 46]. Pre-
incubation of monocytes with SDF-1 enhances adhesion to
activated human umbilical vein endothelial cells [47]. Bone
marrow derived stromal cells are capable of producing large
amounts of VEGF, basic fibroblast growth factor, and MCP-1
[48]. So monocyte depletion may not only reduce interaction
of macrophages with RPE cells, but also cause a negative
cycle that exacerbates reduction of angiogenic factors, BMC
recruitment, and ultimately CNV formation. We propose that
finding ways to prevent contact between monocytes and RPE
cells may lead to new techniques for inhibiting CNV.
Our findings showed that early reduction of monocyte
infiltration into laser spot could reduce recruitment and
incorporation of BMCs into experimental CNV, and SDF-1
expression in laser lesions. Together with the finding that
contact between monocytes and RPE cells directly promot-
ed SDF-1 expression in RPE cells in vitro, we postulate that
monocytes/macrophages have a pivotal role in promoting
vasculogenesis in CNV by enhancing SDF-1 expression.
This provided a feasible mechanism for the function of
monocytes in CNV. An understanding of the interactions
between monocytes, local angiogenic factors, and RPE
cells may constitute a critical platform for new therapeutic
strategies for CNV.
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